top of page

Low-Dose Amikacin as Alternative Treatment for Multidrug-Resistant Tuberculosis

Low-dose amikacin with appropriate dose adjustment based on adequate monitoring demonstrated limited toxicity with positive outcomes as a treatment option for multidrug-resistant tuberculosis (MDR-TB), according to the findings of a retrospective cohort study published in BMC Infectious Diseases. Read here
11 views0 comments

Recent Posts

See All


bottom of page